SCHEMBL17593554

SCHEMBL17593554

NC(=O)C(c1ccccc1)(c1cccnc1)c1ccc2[nH]ncc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
JAK2 O60674 1/20 0.44
KCNN4 O15554 6/20 0.44
ROCK2 O75116 3/20 0.43
CTNNB1 P35222 2/20 0.43
WNT3A P56704 2/20 0.43
ROCK1 Q13464 2/20 0.43
PIM1 P11309 1/20 0.41
PIM3 Q86V86 1/20 0.41
PIM2 Q9P1W9 1/20 0.41
DYRK3 O43781 1/20 0.41
CLK1 P49759 1/20 0.41
CLK2 P49760 1/20 0.41
CLK3 P49761 1/20 0.41
GSK3B P49841 1/20 0.41
CDK5 Q00535 1/20 0.41
DYRK1A Q13627 1/20 0.41
CDK5R1 Q15078 1/20 0.41
DYRK2 Q92630 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17598043 0.84 PIM1 (0.48) NPC1RAB9AJAK2KCNN4ROCK2
SCHEMBL17591695 0.84 KCNN4 (0.39) KCNN4PIM1PIM3PIM2CYP3A4
SCHEMBL17593780 0.82 PIM1 (0.42) NPC1RAB9AJAK2ROCK2CTNNB1
SCHEMBL17592012 0.81 KCNN4 (0.56) KCNN4ALDH1A1MAPTCYP3A4
SCHEMBL17593814 0.81 PIM1 (0.41) NPC1RAB9AJAK2ROCK2CTNNB1
SCHEMBL18454467 0.81 NAMPT (0.39) KCNN4ROCK2CTNNB1WNT3AROCK1
SCHEMBL17594429 0.80 PIM1 (0.40) NPC1RAB9AJAK2ROCK2CTNNB1
SCHEMBL17594159 0.80 CYP3A4 (0.42) NPC1RAB9AJAK2ROCK2CTNNB1
SCHEMBL29931793 0.80 CYP3A4 (0.42) NPC1RAB9AJAK2ROCK2CTNNB1
SCHEMBL17592815 0.78 PIM1 (0.45) NPC1RAB9AKCNN4CTNNB1WNT3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017024021-A1 3-(1H-PYRROLO[2,3-B]PYRIDIN-2-YL)-1H-INDAZOLES AND THERAPEUTIC USES THEREOF SAMUMED, LLC (US) 2017-02-09 WO claimed
WO-2016040185-A1 2-(1H-INDAZOL-3-YL)-3H-IMIDAZO[4,5-B]PYRIDINE AND THERAPEUTIC USES THEREOF SAMUMED, LLC (US) 2016-03-17 WO claimed